Skip to content

Validation of the Neuropsychiatric Fluctuations Scale (EFN-VALID))

French Validation Study of a New Scale for Neuropsychiatric Fluctuations in Parkinson Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04455074
Acronym
EFN-VALID
Enrollment
130
Registered
2020-07-02
Start date
2020-09-23
Completion date
2023-03-23
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluctuating Mood Symptoms, Parkinson Disease

Brief summary

Neuropsychiatric fluctuations (NF) are among the most disabling non motor fluctuations in Parkinson disease (PD). The investigators developed the NF-scale for acute assessment of non-motor neuropsychiatric fluctuations between the off- and on-medication conditions in PD. The main goal of this project is to validate the NF-scale in french language in a multicenter approach.

Detailed description

Anxiety, sadness, lack of energy and motivation, fatigue and pain are common during the off-medication condition, whereas euphoria, well-being, impulse control disorders, behavioral addictions, mania, and psychosis might occur during the on-medication condition. Early diagnosis of NpsyF is crucial for their holistic management. Unfortunately, NpsyF are often under-recognized by patients or misdiagnosed by physicians due to the lack of specific assessment tools. The NFS is composed of 20 items among which ten measure the ON neuropsychological state and ten, the OFF neuropsychological state. It provides two sub-scores (one ON and one OFF) with a maximal total score of 30.

Interventions

OTHERFN scale auto-questionnaire

Patients will be asked to fill in the NF scale questionnaire together with other tests and rating scales, during a routine L-Dopa test, in 2 conditions: OFF-med and ON-med.

Sponsors

University Hospital, Clermont-Ferrand
CollaboratorOTHER
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Idiopathic Parkinson's disease * presence of motor fluctuations, requiring a levodopa test * french native speaker

Exclusion criteria

* Dementia (MoCa \< 24) * Parkinson syndrome other than idiopathic PD * people excluded according to french law (including pregnant women or nursing mothers, ...)

Design outcomes

Primary

MeasureTime frameDescription
validation of FN scale: acceptability4 hoursEFN score
validation of FN scale: realiability2 monthsEFN score
validation of FN scale: internal consistency4 hoursEFN score
validation of FN scale: measurement error2 monthstest-retest
validation of FN scale: structural validity4 hoursEFN score
validation of FN scale: responsiveness4 hours

Secondary

MeasureTime frameDescription
correlation of EFN scores with socio-clinical characteristics 24 hoursSeverity of PD (Clinical Impression of Severity Index for PD - CISI-PD)
correlation of EFN scores with socio-clinical characteristics 34 hoursstage of PD (Hoehn & Yahr stage)
correlation of EFN scores with socio-clinical characteristics (4)4 hourscognitif state (Montreal cognitive assessment - MoCA test)
correlation of EFN scores with socio-clinical characteristics (9)4 hoursEvalulation of impulsive behavior (UPSS)
correlation of EFN scores with socio-clinical characteristics (8)4 hoursDepression (Beck depression inventory BDI-II)
correlation of EFN scores with socio-clinical characteristics (5)4 hoursImpulsive-Compulsive Disorders (QUIP-RS)
correlation of EFN scores with socio-clinical characteristics (6)4 hoursDopamine-dependant behavior (ACDD)
correlation of EFN scores with socio-clinical characteristics (7)4 hoursWearing off (QUICK questionnaire)
correlation of EFN scores with socio-clinical characteristics 14 hoursMDS-UPDRS

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026